Gyre Therapeutics (GYRE) Capital Expenditures Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -53.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.25% |
| Sep 30, 2024 | 12.10% |
| Sep 30, 2023 | 116.32% |
| Jun 30, 2023 | 436.95% |
| Mar 31, 2023 | 367.95% |
| Mar 31, 2020 | 78.28% |
| Dec 31, 2019 | -26.16% |
| Sep 30, 2019 | -64.31% |
| Jun 30, 2019 | -40.70% |
| Mar 31, 2019 | -44.76% |
| Dec 31, 2018 | 21.32% |
| Dec 31, 2016 | 63.77% |
| Jun 30, 2016 | 120.23% |
| Mar 31, 2016 | 8.33% |
| Dec 31, 2015 | -20.49% |
| Dec 31, 2013 | -26.65% |